Nogacka, A; Salazar, N; Arboleya, S; Suárez, M; Fernández, N; Solís, G; de los Reyes-Gavilán, CG and Gueimonde, M. 2018. Early Microbiota, antibiotics and health. Cellular and Molecular Life Sciences 75: 83-91 (doi: 10.1007/s00018-017-2670-2)
Fernández-Navarro, T; Salazar, N; Gutiérrez-Díaz, I; Sánchez, B; Ruas-Madiedo, P; de los Reyes-Gavilan, CG; Margolles, A; Gueimonde, M and González, S. 2018. Bioactive compounds from regular diet and faecal microbial metabolites. European Journal of Nutrition 57: 487-497 (doi: 10.1007/s00394-016-1332-8).
Rios-Covián, D; Nogacka, A; Salazar, N; Hernández-Barranco, AM; Cuesta, I; Gueimonde, M and de los Reyes-Gavilán, CG. 2018. Bifidobacterium breve IPLA20005 affects “in vitro” the expression of hly and luxS genes, related to the virulence of Listeria monocytogenes Lm23. Canadian Journal of Microbiology 64: 215-221 (doi: 10.1139/cjm-2017-0625)
Gil-Sánchez, I; Esteban-Fernández,A; González de Llano, D; Sanz-Buenhombre, M; Guadarrana, A; Salazar, N; Gueimonde,M; de los Reyes-Gavilán, CG; Martín Gómez, L; García Bermejo, ML; Bartolomé, B and Moreno-Arribas MV. 2018. Supplementation with grape pomace in healthy women: changes in biochemical parameters, gut microbiota and related metabolic biomarkers. Journal of Functional Foods 45: 34-46 (doi: 1016/j.jff.2018.03.031)
Olivares, M; Neyrinck AM; Pötgens, SA; Beaumont, M; Salazar, N; Cani, PD; Bindels, LB and Delzenne, NM. 2018. The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice. Diabetologia 61: 1838-1848 (doi: 10.1007/s00125-018-4647-6)
Arboleya, S; Suárez, M; Fernández, N; Mantecón, L; Solís,G; Gueimonde, M and de los Reyes-Gavilán, CG. 2018. C-section and the neonatal gut microbiome acquisition: consequences for future health. Annals of Nutrition and Metabolism 73 (suppl 3): 17-23 (doi: 10.1159/000490843)
Nogacka, AM; Ruas-Madiedo,P; Gómez, E; Fernández, N; Suárez, M; Suárez, A; Salazar, N; de los Reyes-Gavilán, CG and Gueimonde, M. 2018. Real-time monitoring ofHT29 epithelial cellsas an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups. Journal of Microbiological Methods 152: 210-216 (doi:10.1016/j.mimet.2018.07.003)
Gutiérrez-Díaz, I; Fernández-Navarro, T; Salazar, N; Bartolomé, B; Moreno-Arribas, MV; López, P; Suárez, A; de los Reyes-Gavilán, CG; Gueimonde, M and González, S. 2018. Could fecalphenylacetic and phenylpropionic acids be used as indicators of health status? Journal of Agricultural and Food Chemistry 66: 10538-10446 (doi: 10.1021/acs.jafc.8b04102X)
Moris, G; Arboleya, S; Mancabelli, L; Milani, Ch; Ventura, M; de los Reyes-Gavilán, CG and Gueimonde, M. 2018. Fecal microbiota profile in a group of myasthenia gravis patients. Scientific Reports 8: 14384 (doi:10.1038/s41598-018-32700-y)
